Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 14, 2022

View Archived Issues

NOS targeting to treat ischemic stroke

Serum PRO-C6 monitors and predicts infliximab response in patients with Crohn's disease

New TLR8 agonists identified at National Institute of Pharmaceutical R&D Co.

FLT3 inhibitors discovered at Cytosinlab Therapeutics

Janssen Pharmaceutica presents new factor XIa inhibitors

Roche patents vasopressin V1A receptor antagonists

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical identify new SOS1 inhibitors

Targeting sphingolipid synthesis has multiple beneficial effects in Duchenne model

SAF-248 shows potent activity against DLBCL in vitro and in vivo

STC-2 administration confers post-stroke functional recovery in a preclinical model

R2M3-26, a novel Wnt mimetic with promising efficacy in mouse model of colitis

3-beta-HSD linked to depression in males due to testosterone degradation

JN Nova advances COVID-19 therapeutic JN-2019 into clinic

T-cell evasion is one pressure shaping SARS-CoV-2 evolution

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...